CHICAGO Ill. (October 17, 2017) - Perkins Coie represented Attune Medical, the developer of EnsoETM, the only patient temperature management system approved for use in the esophageal environment for whole-body temperature modulation, in the close of a $10 million Series C financing with participation from existing investors, several associates, and new investors.

Led by Chicago partner John Schreiner, the Perkins Coie team included Chicago associate Sarah David.

Please click here to read the Attune Medical press release.

Perkins Coie is a leading international law firm that is known for providing high-value, strategic solutions and extraordinary client service on matters vital to our clients’ success. With more than 1,200 lawyers in offices across the United States and Asia, we provide a full array of corporate, commercial litigation, intellectual property, and regulatory legal advice to a broad range of clients, including many of the world’s most innovative companies and industry leaders as well as public and not-for-profit organizations.

Media Inquiries: Please email Justin Cole, Head of Media Relations.